The Role of Emerging Therapies for Retinal Disease in Clinical Practice
Manage episode 363482014 series 3381434
Innhold levert av ReachMD. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av ReachMD eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
CME credits: 1.00
Valid until: 15-05-2024
Claim your CME credit at https://reachmd.com/programs/cme/role-emerging-therapies-retinal-disease-clinical-practice/15444/
This program will focus on the clinical trial and real-world data about the novel and emerging therapies for the treatment of dry age-related macular degeneration, wet age-related macular degeneration, diabetic retinopathy, and diabetic macular edema and how these therapies may be integrated into real-world clinical practice. =
…
continue reading
Valid until: 15-05-2024
Claim your CME credit at https://reachmd.com/programs/cme/role-emerging-therapies-retinal-disease-clinical-practice/15444/
This program will focus on the clinical trial and real-world data about the novel and emerging therapies for the treatment of dry age-related macular degeneration, wet age-related macular degeneration, diabetic retinopathy, and diabetic macular edema and how these therapies may be integrated into real-world clinical practice. =
1926 episoder
Del
))
